Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance.
Trypanosoma brucei rhodesiense (Tbr) and T. b. gambiense (Tbg), causative agents of Human African Trypanosomiasis (sleeping sickness) in Africa, have evolved alternative mechanisms of resisting the activity of trypanosome lytic factors (TLFs), components of innate immunity in human serum that protec...
Saved in:
Main Authors: | Rebecca E Symula (Author), Jon S Beadell (Author), Mark Sistrom (Author), Kehinde Agbebakun (Author), Oliver Balmer (Author), Wendy Gibson (Author), Serap Aksoy (Author), Adalgisa Caccone (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phylogeography and taxonomy of Trypanosoma brucei.
by: Oliver Balmer, et al.
Published: (2011) -
Genetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and Nagana.
by: Richard Echodu, et al.
Published: (2015) -
Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.
by: Vincent Jamonneau, et al.
Published: (2012) -
A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
by: Anneli Cooper, et al.
Published: (2016) -
Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.
by: Liesbeth Carolien Van Nieuwenhove, et al.
Published: (2011)